Vector Science and Therapeutics Corp.
PAIN.V
TSX
| 02/28/2026 | 11/30/2025 | ||||
|---|---|---|---|---|---|
| Net Income | -241.10K | -987.80K | |||
| Total Depreciation and Amortization | 3.30K | 2.60K | |||
| Total Amortization of Deferred Charges | -- | -- | |||
| Total Other Non-Cash Items | -78.20K | 72.70K | |||
| Change in Net Operating Assets | -836.20K | 79.60K | |||
| Cash from Operations | -1.15M | -832.80K | |||
| Capital Expenditure | -1.70K | -83.10K | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | -1.40K | -14.20K | |||
| Cash from Investing | -3.10K | -97.40K | |||
| Total Debt Issued | -200.00 | 800.00 | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | -- | 125.30K | |||
| Repurchase of Common Stock | -34.20K | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | 0.00 | -25.70K | |||
| Cash from Financing | -34.40K | 100.40K | |||
| Foreign Exchange rate Adjustments | -- | -- | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | -1.19M | -829.80K | |||